Protas is delighted to have welcomed Esther Krofah MPP to its Board of Directors.
Esther, who joined the board this April, brings to Protas extensive experience in managing efforts to solve critical issues in healthcare and improve patients’ lives through uniting stakeholders and achieving shared goals.
In her current position as Executive Vice President of Health for the Milken Institute, Esther is responsible for the direction of FasterCures, the Centre for Public Health, Feeding Change and the Centre for the Future of Aging.
Prior to this, Esther served as the Director of Public Policy at GlaxoSmithKline and held roles in the United States government and consulting to advance health reform.
She received a BA from Duke University and a Master of Public Policy from Harvard University’s John F Kennedy School of Government.
Lord Prior of Brampton, Chairman of the Board at Protas, said: “Esther is an outstanding addition to the Protas board, bringing many years of expertise in senior and high-profile healthcare initiatives from the US and globally.
“Our central mission at Protas is to reduce the global burden of chronic and infectious disease. Esther’s vast experience in this field will make a major contribution to this. I am delighted to welcome her to the board.”
Esther said: “I am proud to support the work of Protas in building the clinical trial design and execution of the future, as this is a critical component of improving health equity across the biomedical research ecosystem.
“I look forward to advancing collaboration across industries to help break down silos, encourage innovative approaches, leverage areas of expertise, and accelerate action to meet the needs of patients and communities.”
The Protas Board of Directors has overall responsibility for the direction and management of Protas, working collectively to achieve the organisation’s aims. Its members bring together broad expertise from across clinical, scientific, academic, government and corporate backgrounds.